<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://www.fiercepharma.com" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>Merck</title>
 <link>http://www.fiercepharma.com/tags/merck</link>
 <description></description>
 <language>en</language>
<item>
 <title>Did GSK ignore early abacavir warning?</title>
 <link>http://www.fiercepharma.com/story/did-gsk-ignore-early-abacavir-warning/2008-05-12?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FP0</link>
 <description>Back in 2005, Swedish pharma monitors raised a red flag on the HIV fighter abacavir and its possible link to heart attacks, The Independent is reporting. Thirty-four patients taking abacavir had &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercepharma.com/story/did-gsk-ignore-early-abacavir-warning/2008-05-12&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <comments>http://www.fiercepharma.com/story/did-gsk-ignore-early-abacavir-warning/2008-05-12#comments</comments>
 <category domain="http://www.fiercepharma.com/tags/abacavir">Abacavir</category>
 <category domain="http://www.fiercepharma.com/tags/drug-safety">drug safety</category>
 <category domain="http://www.fiercepharma.com/tags/glaxosmithkline">GlaxoSmithKline</category>
 <category domain="http://www.fiercepharma.com/tags/hiv">HIV</category>
 <category domain="http://www.fiercepharma.com/tags/merck">Merck</category>
 <pubDate>Mon, 12 May 2008 06:59:55 -0400</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">9002 at http://www.fiercepharma.com</guid>
</item>
<item>
 <title>Merck layoffs inspire poets to versify</title>
 <link>http://www.fiercepharma.com/story/merck-layoffs-inspire-poets-to-versify/2008-05-08?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FP0</link>
 <description>Curious what one &lt;A href=&quot;http://www.fiercepharma.com/story/merck-to-cut-1200-sales-reps/2008-05-06?utm_medium=rss&amp;amp;utm_source=rss&amp;amp;cmp-id=OTC-RSS-FP0&quot;&gt;laid-off Merck rep&lt;/a&gt; thinks about the &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercepharma.com/story/merck-layoffs-inspire-poets-to-versify/2008-05-08&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <comments>http://www.fiercepharma.com/story/merck-layoffs-inspire-poets-to-versify/2008-05-08#comments</comments>
 <category domain="http://www.fiercepharma.com/tags/cordaptive">Cordaptive</category>
 <category domain="http://www.fiercepharma.com/tags/layoffs">layoffs</category>
 <category domain="http://www.fiercepharma.com/tags/merck">Merck</category>
 <pubDate>Thu, 08 May 2008 06:59:54 -0400</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">8986 at http://www.fiercepharma.com</guid>
</item>
<item>
 <title>FDA panel rejects broader Fentora use</title>
 <link>http://www.fiercepharma.com/story/fda-panel-rejects-broader-fentora-use/2008-05-07?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FP0</link>
 <description> No go, Fentora. An FDA advisory panel voted against &lt;a href=&quot;http://www.fiercepharma.com/story/expert-panel-to-mull-broader-fentora-use/2008-05-02&quot;&gt;broadening the use of Cephalon&#039;s painkiller&lt;/a&gt;, &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercepharma.com/story/fda-panel-rejects-broader-fentora-use/2008-05-07&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <comments>http://www.fiercepharma.com/story/fda-panel-rejects-broader-fentora-use/2008-05-07#comments</comments>
 <category domain="http://www.fiercepharma.com/tags/cephalon">Cephalon</category>
 <category domain="http://www.fiercepharma.com/tags/cordaptive">Cordaptive</category>
 <category domain="http://www.fiercepharma.com/tags/fentora">Fentora</category>
 <category domain="http://www.fiercepharma.com/tags/merck">Merck</category>
 <pubDate>Wed, 07 May 2008 06:59:57 -0400</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">8964 at http://www.fiercepharma.com</guid>
</item>
<item>
 <title>U.S. Attys probe Schering over Vytorin</title>
 <link>http://www.fiercepharma.com/story/u.s.-attys-probe-schering-over-vytorin/2008-05-07?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FP0</link>
 <description> The ranks of investigators probing Schering-Plough and its Vytorin drug are broadening. In a recent SEC filing, Schering disclosed that U.S. Attorneys have been asking for info and documents related &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercepharma.com/story/u.s.-attys-probe-schering-over-vytorin/2008-05-07&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <comments>http://www.fiercepharma.com/story/u.s.-attys-probe-schering-over-vytorin/2008-05-07#comments</comments>
 <category domain="http://www.fiercepharma.com/tags/fred-hassan">Fred Hassan</category>
 <category domain="http://www.fiercepharma.com/tags/merck">Merck</category>
 <category domain="http://www.fiercepharma.com/tags/schering-plough">Schering-Plough</category>
 <category domain="http://www.fiercepharma.com/tags/vytorin">Vytorin</category>
 <category domain="http://www.fiercepharma.com/tags/zocor">Zocor</category>
 <pubDate>Wed, 07 May 2008 06:59:55 -0400</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">8962 at http://www.fiercepharma.com</guid>
</item>
<item>
 <title>Merck to cut 1,200 sales reps</title>
 <link>http://www.fiercepharma.com/story/merck-to-cut-1200-sales-reps/2008-05-06?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FP0</link>
 <description> The axeman cometh to Merck&#039;s sales force. The drugmaker plans to lop off about 15 percent in the sales ranks, or 1,200 jobs. The fact that it&#039;s not alone in trimming back on reps--Wyeth just &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercepharma.com/story/merck-to-cut-1200-sales-reps/2008-05-06&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <comments>http://www.fiercepharma.com/story/merck-to-cut-1200-sales-reps/2008-05-06#comments</comments>
 <category domain="http://www.fiercepharma.com/tags/layoffs">layoffs</category>
 <category domain="http://www.fiercepharma.com/tags/merck">Merck</category>
 <category domain="http://www.fiercepharma.com/tags/pharmaceutical-sales-and-marketing">Pharmaceutical sales and marketing</category>
 <category domain="http://www.fiercepharma.com/tags/vytorin">Vytorin</category>
 <category domain="http://www.fiercepharma.com/tags/wyeth">Wyeth</category>
 <pubDate>Tue, 06 May 2008 06:59:58 -0400</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">8957 at http://www.fiercepharma.com</guid>
</item>
<item>
 <title>Pfizer starts settling Celebrex claims</title>
 <link>http://www.fiercepharma.com/story/pfizer-starts-settling-celebrex-claims/2008-05-05?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FP0</link>
 <description> Pfizer is starting to settle the thousands of lawsuits over painkillers Celebrex and Bextra, the Wall Street Journal reports. Three groups of plaintiffs who allege that the meds caused heart attacks &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercepharma.com/story/pfizer-starts-settling-celebrex-claims/2008-05-05&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <comments>http://www.fiercepharma.com/story/pfizer-starts-settling-celebrex-claims/2008-05-05#comments</comments>
 <category domain="http://www.fiercepharma.com/tags/bextra">Bextra</category>
 <category domain="http://www.fiercepharma.com/tags/celebrex">Celebrex</category>
 <category domain="http://www.fiercepharma.com/tags/lawsuit">lawsuit</category>
 <category domain="http://www.fiercepharma.com/tags/merck">Merck</category>
 <category domain="http://www.fiercepharma.com/tags/pfizer">Pfizer</category>
 <category domain="http://www.fiercepharma.com/tags/vioxx">Vioxx</category>
 <pubDate>Mon, 05 May 2008 06:59:58 -0400</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">8950 at http://www.fiercepharma.com</guid>
</item>
<item>
 <title>Vagelos: Cut prices to cure &#039;black eye&#039;</title>
 <link>http://www.fiercepharma.com/story/vagelos-cut-prices-to-cure-black-eye-/2008-05-05?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FP0</link>
 <description>Pharma needs to slap some raw steak on its black eye, Dr. Roy Vagelos said during a speech last week. Pharma&#039;s elder statesman--and ex-Merck CEO--says the drug industry has lost goodwill and &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercepharma.com/story/vagelos-cut-prices-to-cure-black-eye-/2008-05-05&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <comments>http://www.fiercepharma.com/story/vagelos-cut-prices-to-cure-black-eye-/2008-05-05#comments</comments>
 <category domain="http://www.fiercepharma.com/tags/developing-world">developing world</category>
 <category domain="http://www.fiercepharma.com/tags/emerging-markets">emerging markets</category>
 <category domain="http://www.fiercepharma.com/tags/merck">Merck</category>
 <pubDate>Mon, 05 May 2008 06:59:56 -0400</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">8948 at http://www.fiercepharma.com</guid>
</item>
<item>
 <title>Merck CEO: &#039;I can&#039;t blame the media&#039;</title>
 <link>http://www.fiercepharma.com/story/merck-ceo-i-can-t-blame-the-media-/2008-05-02?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FP0</link>
 <description> A triad of Merck news today, including one item about the news. We&#039;ll start with that: CEO Dick Clark (&lt;a href=&quot;http://www.fiercebiotech.com/story/merck-ceo-richard-clark/2006-11-12&quot;&gt;photo&lt;/a&gt;) &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercepharma.com/story/merck-ceo-i-can-t-blame-the-media-/2008-05-02&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <comments>http://www.fiercepharma.com/story/merck-ceo-i-can-t-blame-the-media-/2008-05-02#comments</comments>
 <category domain="http://www.fiercepharma.com/tags/merck">Merck</category>
 <category domain="http://www.fiercepharma.com/tags/public-trust">public trust</category>
 <category domain="http://www.fiercepharma.com/tags/richard-clark">Richard Clark</category>
 <category domain="http://www.fiercepharma.com/tags/vioxx">Vioxx</category>
 <category domain="http://www.fiercepharma.com/tags/vytorin">Vytorin</category>
 <pubDate>Fri, 02 May 2008 06:59:57 -0400</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">8942 at http://www.fiercepharma.com</guid>
</item>
<item>
 <title>DTC hearing has high-powered guest list</title>
 <link>http://www.fiercepharma.com/story/dtc-hearing-has-high-powered-guest-list/2008-05-02?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FP0</link>
 <description> Hail, hail the gang&#039;s all here...at the House Subcommittee on Oversight and Investigations hearing on direct-to-consumer ads. Next week, Rep. Bart Stupak will preside over testimony from Pfizer, &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercepharma.com/story/dtc-hearing-has-high-powered-guest-list/2008-05-02&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <comments>http://www.fiercepharma.com/story/dtc-hearing-has-high-powered-guest-list/2008-05-02#comments</comments>
 <category domain="http://www.fiercepharma.com/tags/dtc-advertising">DTC advertising</category>
 <category domain="http://www.fiercepharma.com/tags/merck">Merck</category>
 <category domain="http://www.fiercepharma.com/tags/pfizer">Pfizer</category>
 <category domain="http://www.fiercepharma.com/tags/stupak">Stupak</category>
 <pubDate>Fri, 02 May 2008 06:59:54 -0400</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">8939 at http://www.fiercepharma.com</guid>
</item>
<item>
 <title>Merck warned on vaccine plant problems</title>
 <link>http://www.fiercepharma.com/story/merck-warned-on-vaccine-plant-problems/2008-05-01?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FP0</link>
 <description> Last week, &lt;a href=&quot;http://www.fiercebioresearcher.com/vaccines/story/fda-orders-merck-to-fix-vaccine-plant-problems/2008-05-01&quot;&gt;we heard the warning would be coming&lt;/a&gt;. And here it is. The FDA has &lt;span class=&#039;read-more&#039;&gt;&lt;a href=&quot;http://www.fiercepharma.com/story/merck-warned-on-vaccine-plant-problems/2008-05-01&quot;&gt;Read more...&lt;/a&gt;&lt;/span&gt;</description>
 <comments>http://www.fiercepharma.com/story/merck-warned-on-vaccine-plant-problems/2008-05-01#comments</comments>
 <category domain="http://www.fiercepharma.com/tags/drug-safety">drug safety</category>
 <category domain="http://www.fiercepharma.com/tags/merck">Merck</category>
 <category domain="http://www.fiercepharma.com/tags/vaccine-plant">vaccine plant</category>
 <pubDate>Thu, 01 May 2008 06:59:56 -0400</pubDate>
 <dc:creator>admin</dc:creator>
 <guid isPermaLink="false">8934 at http://www.fiercepharma.com</guid>
</item>
</channel>
</rss>
